Figure 2From: Systematic review, network meta-analysis and economic evaluation of biological therapy for the management of active psoriatic arthritis Results from 1,000 model simulations. Upper panel: incremental cost and QALYs for etanercept plotted on cost-effectiveness plane; lower panel: percentage of simulations where treatment has highest net monetary benefit at varying WTP thresholds.Back to article page